Angela Waanders, MD, MPH
Specialties:Hematology, Oncology, Neuro-Oncology & Stem Cell TransplantationEducation: Tulane University School of Medicine, 2003Postgraduate Training: Fellowship in pediatric hematology/oncology, Children's Hospital of Philadelphia, 2006-2009; Residency is pediatrics, Children's Hospital of Philade
Oren J. Becher, MD
My laboratory uses genetic mouse modeling tools to study Diffuse Intrinsic Pontine Glioma (DIPG), an incurable brain cancer that arises in children. Our three aims are to develop improved DIPG mouse models, to study the mechanism of novel oncogenes implicated in DIPG pathogenesis (e.g., H3K27M, ACVR
Ann & Robert H. Lurie Children’s Hospital of Chicago treats 220 new patients each year with pediatric cancers. The hospital is ranked 17th in the nation for their pediatric oncology program and 11th for their neurology and neurosurgery program by U.S. News & World Report.
Established in 1986, the Lurie Brain Tumor Center offers patients new treatments such as proton therapy, as well as access to treatments through numerous ongoing clinical studies. Lurie’s Brain Tumor Board completes comprehensive reviews of children's cases each week, and the Brain Tumor Center offers highly specialized and state-of the-art care for children of all ages.
Home institution for the current CBTTC chair, Dr. Angela Waanders, Lurie Children's was one of the four original sites to share their data through the CBTTC. CBTTC investigators Dr. Stewart Goldman and Dr. Oren Becher are currently working on a project that aims to identify genetic alterations that correlate with radiation injury.
Melissa Williams | Clinical Research Coordinatorhttps://www.luriechildrens.org/
CBTN participation made possible by
CBTN Executive Council
Winning With Wyatt
Why did you start your foundation?Winning With Wyatt supports pediatric brain tumor research and advocacy through leading institutions, including the Ann & Robert H. Lurie Children’s Hospital of Chicago and the Children’s Brain Tumor Network, to find new treatments and a cure for the disease that is
La Grange, Il
Xiao-Nan Li, MD, PhD
Development of novel patient derived orthotopic xenograft mouse models, understand tumor biology and identify new diagnostic and/or therapeutic targets, perform comprehensive preclinical drug testing to establish preclinical rational for the initiation of clinical trials.
Amanda Muhs Saratsis, MD
Dr. Saratsis has clinical appointments in the Departments of Neurological Surgery at Northwestern Memorial and Lurie Children's Hospitals, caring for children and adults with congenital disorders of the central nervous system. Dr. Saratsis has expertise in the clinical management and molecular biolo
Nitin Wadhwani, MD
Pediatric central nervous system tumors, spinal dysraphism
Stewart Goldman, MD
Stewart Goldman, MD is the head of the Division of Hematology, Oncology and Stem Cell Transplantation at the Ann & Robert H. Lurie Children's Hospital of Chicago and a professor in the Department of Pediatrics at Northwestern University Feinberg School of Medicine.Goldman is the medical director and
Ashley Plant, MD
Dr. Plant is a pediatric neuro-oncologist with a focus on early phase clinical trials for pediatric brain tumors and immunotherapy.
Rintaro Hashizume, MD, PhD
Dr. Hashizume's primary research interests in understanding of the molecular mechanisms, that affect the aggressive/ invasive biological behavior of pediatric malignant glioma and would accordingly reveal potential therapeutic targets for glioma therapy.
Melissa Williams, BA
I’m Melissa Williams, Gift From a Child Tissue Navigator at Lurie Children’s Hospital. More than fifteen years ago I began a journey with donation. I worked for Gift of Hope Organ & Tissue Donor Network as a liaison with funeral directors and forensic professionals. There, I transitioned to a Design
Guifa Xi, MD, PhD
Pediatric gliomas are among the most formidable and devastating cancers in children. Surgery followed by radio- and/or chemotherapy is often ineffective due to chemo- and/or radio-resistance. Our research is focusing on the role of posttranslational histone protein modifications in therapeutic resi
Elizabeth Sokol, MD
When I was deciding where I wanted to pursue a fellowship in Heme/Onc, early on I came to the realization that Comer was the place for me. There is a great balance between both research and clinical practice. We have the advantage of being a growing section within an amazing research institution wit
Kai Lee Yap, PhD
Dr. Yap is Director of the Lurie Children's Molecular Diagnostics Laboratory located at the Lincoln Park Outpatient Center. Her clinical expertise lies in the genetic diagnosis of pediatric constitutional disorders and childhood malignancies. Prior to joining Lurie in 2017, she completed her Clinica
Sabah Kadri, PhD
I have a PhD in Computational Biology from the Joint CMU-UPitt Computational Biology Program at Carnegie Mellon University and currently work as Director of Bioinformatics at Lurie Children's Hospital of Chicago and Assistant Professor of Pathology at Northwestern University.As a scientist , I am in
Raj Mudahar, MBA, BCPS, PharmD
Tina Huang is a Research Technologist at the Saratsis Pediatric Brain Tumor Laboratory at the NorthWestern University. Some of her most prominent research includes the "Detection of Histone H3 mutations in cerebrospinal fluid-derived tumor DNA from children with diffuse midline glioma" and "Npas1+